Lindbrook Capital, LLC - ONCOCYTE CORP ownership

Back to all holdings Add to watchlist

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 53 filers reported holding ONCOCYTE CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2023$20
-33.3%
860.0%0.00%–
Q1 2023$30
+7.1%
860.0%0.00%–
Q4 2022$28–860.0%0.00%–
Q3 2022$0–860.0%0.00%–
Q2 2022$0–860.0%0.00%–
Q1 2022$0–860.0%0.00%–
Q4 2021$0
-100.0%
86
-55.7%
0.00%–
Q3 2021$1,000–194–0.00%–
 Download
Other shareholders
ONCOCYTE CORP shareholders Q1 2023
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 1,093,219$6,833,0001.15%
HUNTINGTON NATIONAL BANK 10$00.00%
CITIGROUP INC 642$4,0000.00%
Sonora Investment Management, LLC 50$00.00%
BARCLAYS PLC 206$1,0000.00%
BLACKROCK ADVISORS LLC 96$1,0000.00%
View complete list of ONCOCYTE CORP shareholders